Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR for Cognitive Impairment in Bipolar Disorder
NCT00746421Phase 4Terminated
- Sponsor
- Emory University
- Start
- Jan 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar disorder (BD), sponsored by Emory University. Started Jan 2010; status: terminated.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00746421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746421.